FDA

Changes to the label for tilmicosin injection were approved by the FDA to address the risk to humans who handle or administer the drug

The bexagliflozin product (Bexacat; Increvet Inc) is also the first SGLT2 inhibitor new animal drug approved by the FDA in any animal species.

First drug approved for the management of acute onset of canine pancreatitis

This topical drug for humans is a deadly threat to pets

Both fluralaner topical solution (Bravecto) and fluralaner and moxidectin topical solution (Bravecto Plus) are now indicated for the treatment and control of Asian longhorned tick infestations in cats.

The product from Boehringer Ingelheim promotes the development of antibodies against rotavirus, coronavirus, and E. coli F5 (K99) adhesin

Registration is now open to attend the FDA event

These tablets will help treat pain and inflammation in connection to osteoarthritis in equine patients

Study will focus on effects of CBD and CBG for canine elbow osteoarthritis

Dechra’s alpha-2 combination drug is indicated to minimize stress surrounding canine sedation

This chewable tablet is the first drug on the market for delaying the onset of Stage B2 preclinical myxomatous mitral valve disease in canines

Pharmaceutical sponsors who meet the eligibility requirements or their research partners are encouraged to apply.

Tulathromycin injection is an option for bovine respiratory disease, and other conditions

The new dry cat food that will alleviate feline hairballs is now available in stores

Jaguar Animal Health’s crofelemer product has conditional approval from the FDA

The document expands upon the original guidance #106 by considering various uses of the scientific literature to support approval of a new animal drug

The agency will provide outreach and education as part of its’ implementation plan.

3 articles highlighting the latest FDA-approved veterinary drugs

The drug product is a balanced combination of medetomidine and vatinoxan.

The new drug product is indicated for dogs with pain and inflammation associated with osteoarthritis, and postoperative pain and inflammation associated with soft-tissue and orthopedic surgery.

The new prescription drugs from Merck Animal Health are broad-spectrum medications for combating organisms that cause the illness.

Crofelemer (Canalevia-CA1) is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs and could also be used to treat exercise-induced diarrhea.

Frunevetmab injection (Zoetis; Solensia) is the first treatment for pain associated with osteoarthritis in cats.

Antimicrobial stewardship has taken the human health world by storm, and now, it’s securing its place in veterinary medicine.